Pharma Mar, S.A. - Product Pipeline Review - 2014

Published: Sep, 2014 | Pages: 42 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Pharma Mar, S.A. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Pharma Mar, S.A. - Product Pipeline Review - 2014', provides an overview of the Pharma Mar, S.A.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Pharma Mar, S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Pharma Mar, S.A. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Pharma Mar, S.A.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Pharma Mar, S.A.'s pipeline products

Reasons to buy

- Evaluate Pharma Mar, S.A.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Pharma Mar, S.A. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Pharma Mar, S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Pharma Mar, S.A. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Pharma Mar, S.A.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Pharma Mar, S.A. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Pharma Mar, S.A. Snapshot 5
Pharma Mar, S.A. Overview 5
Key Information 5
Key Facts 5
Pharma Mar, S.A. - Research and Development Overview 6
Key Therapeutic Areas 6
Pharma Mar, S.A. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Pharma Mar, S.A. - Pipeline Products Glance 11
Pharma Mar, S.A. - Late Stage Pipeline Products 11
Phase III Products/Combination Treatment Modalities 11
Pharma Mar, S.A. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Pharma Mar, S.A. - Drug Profiles 14
plitidepsin 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
trabectedin 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
lurbinectedin 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
PM-00104 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
PM-060184 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Pharma Mar, S.A. - Pipeline Analysis 24
Pharma Mar, S.A. - Pipeline Products by Target 24
Pharma Mar, S.A. - Pipeline Products by Route of Administration 25
Pharma Mar, S.A. - Pipeline Products by Molecule Type 26
Pharma Mar, S.A. - Pipeline Products by Mechanism of Action 27
Pharma Mar, S.A. - Recent Pipeline Updates 28
Pharma Mar, S.A. - Dormant Projects 34
Pharma Mar, S.A. - Discontinued Pipeline Products 35
Discontinued Pipeline Product Profiles 35
ES-285 35
elisidepsin 35
Pharma Mar, S.A. - Company Statement 36
Pharma Mar, S.A. - Locations And Subsidiaries 40
Head Office 40
Other Locations & Subsidiaries 40
Appendix 41
Methodology 41
Coverage 41
Secondary Research 41
Primary Research 41
Expert Panel Validation 41
Contact Us 42
Disclaimer 42

List of Tables
Pharma Mar, S.A., Key Information 5
Pharma Mar, S.A., Key Facts 5
Pharma Mar, S.A. - Pipeline by Indication, 2014 8
Pharma Mar, S.A. - Pipeline by Stage of Development, 2014 9
Pharma Mar, S.A. - Monotherapy Products in Pipeline, 2014 10
Pharma Mar, S.A. - Phase III, 2014 11
Pharma Mar, S.A. - Phase II, 2014 12
Pharma Mar, S.A. - Phase I, 2014 13
Pharma Mar, S.A. - Pipeline by Target, 2014 24
Pharma Mar, S.A. - Pipeline by Route of Administration, 2014 25
Pharma Mar, S.A. - Pipeline by Molecule Type, 2014 26
Pharma Mar, S.A. - Pipeline Products by Mechanism of Action, 2014 27
Pharma Mar, S.A. - Recent Pipeline Updates, 2014 28
Pharma Mar, S.A. - Dormant Developmental Projects,2014 34
Pharma Mar, S.A. - Discontinued Pipeline Products, 2014 35
Pharma Mar, S.A., Subsidiaries 40